Holdings
Casdin Capital, LLC
As of Jun 30, 2026, Casdin Capital, LLC reported 39 positions worth US$1.89B. Largest: Revolution Medicines, Inc., Relay Therapeutics, Inc. and Genedx Holdings Corp. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Revolution Medicines, Inc. | 2.58M | US$483M | no change | Jun 30, 2026 |
| Relay Therapeutics, Inc. | 16M | US$300M | +1.62M | Jun 30, 2026 |
| Genedx Holdings Corp. | 3.71M | US$254M | +700K | Jun 30, 2026 |
| Biolife Solutions, Inc. | 4.66M | US$131M | −1.3M | Jun 30, 2026 |
| Illumina, Inc. | 530K | US$93.2M | no change | Jun 30, 2026 |
| Standard Biotools Inc. | 88.8M | US$73M | no change | Jun 30, 2026 |
| Denali Therapeutics Inc. | 2.04M | US$52.6M | +205K | Jun 30, 2026 |
| Neurogene Inc. | 1.55M | US$48.6M | +125K | Jun 30, 2026 |
| Beam Therapeutics Inc. | 1.35M | US$46.3M | no change | Jun 30, 2026 |
| 10x Genomics, Inc. | 1.05M | US$40.3M | −1.23M | Jun 30, 2026 |